GLOBAL HEALTH COST CONSORTIUM


The goal of this proposal is to mitigate the TB and HIV epidemics by improving the efficiency and effectiveness of TB and HIV services globally. This project aims to do this by systematically improving the availability, quality, timing, relevance, interpretation, and use of cost information on HIV and tuberculosis (TB) programs and services. Available and accurate cost information is critical to improving the effective use of limited funding, by improving priority setting and informing the design and scale-up of HIV and TB technologies and services globally. Our aim will be achieved through establishing a consortium to lead and inspire a broad range of individuals and organizations with shared interests in such a goal.

We will focus on three major areas: 1) produce useable high quality unit cost data that can be adapted to local settings, 2) foster the efficient collection of high quality cost data, and 3) engage with stakeholders to promote the appropriate use of cost data. In particular we will focus on helping global funders and partners in TB and HIV services, such as PEPFAR, the Global Fund for Aids, Tuberculosis and Malaria, and the World Health Organization – and the country programs they support – use cost data to improve the efficiency and effectiveness of their TB and HIV programs. We will extract, collate and analyze existing cost data sets in order to provide accessible unit cost estimates of TB and HIV services; identify data gaps; and produce guidance for high quality and efficient cost data collection. We will inform a wide range of anticipated stakeholder needs including resource allocation, comprehensive country planning, program efficiency improvement, and the detailed economic evaluation of new technologies. We will support funders of costing studies with data-driven standards, guidelines and costing methods to improve the quality and breadth of costing.

The consortium will be led by the University of Washington (UW), and includes teams at the University of California San Francisco (UCSF), the London School of Hygiene and Tropical Medicine (LSHTM), Avenir Health, Mexico’s National Institute of Public Health (INSP) and the University of Cape Town, South Africa.